Introduction to VPA (vaporized peracetic acid) sterilization; A new path to innovation and Efficiency

14. March 2017

Traditional sterilization methods, such as ethylene oxide (EO), gamma radiation can leave behind dangerous carcinogenic residuals or even damage and degrade a product’s materials or packaging. REVOX has developed a room-temperature sterilization process that uses Vaporized Peracetic Acid (VPA) to gently sterilize all surfaces of a product within its package. This patented technology has excellent penetration capabilities, and leaves behind no residuals. VPA breaks down into relatively harmless, naturally occurring substances: water, oxygen, and carbon dioxide. The safety and easy installation of the REVOX VPA system provides manufacturers the ability to add efficient in-line sterilization to their manufacturing process. VPA has been verified safe and effective for use on over 100 materials, including thermoplastics, adhesives, bio-absorbables, metals, and more, and has been approved as the sterilization method on a FDA 501(k) approved Class II medical device. VPA sterilization makes it possible for manufacturers to safely disinfect products without exposing them to high temperatures, moisture, radiation, or hazardous chemical byproducts. Learn more about VPA, its applications, and how it can work for you.
Mason Schwartz
Inventor of REVOX VPA technology & Director of R&D and Operations
REVOX Sterilization Solutions

More Information & Registration

 

 

You might also like